Details of the Drug Formulations

General Information of Drug (ID: DM7ISKJ)

Drug Name
Nisoldipine Drug Info
Synonyms
Baymycard; Nisocor; Nisoldipin; Nisoldipino; Nisoldipinum; Sular; Syscor; Zadipina; Bay k 5552; Nisoldipino [INN-Spanish]; Nisoldipinum [INN-Latin]; Sular (TN); Bay-k-5552; Nisoldipine (JAN/USAN/INN); Nisoldipine [USAN:BAN:INN:JAN]; Isobutyl 1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridincarboxylat;Methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; (+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester; 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Indication
Disease Entry ICD 11 Status REF
Hypertension BA00-BA04 Approved [1]
Therapeutic Class
Antihypertensive Agents
Cross-matching ID
PubChem CID
4499
ChEBI ID
CHEBI:76917
CAS Number
63675-72-9
TTD ID
D0S5CU
VARIDT ID
DR00668
INTEDE ID
DR1165
ACDINA ID
D00472

Full List of Drug Formulations Containing This Drug

Nisoldipine 17 mg tablet
Company Formulation ID FDA Description
United Research Laboratories F15388 Lactose; Sodium lauryl sulfate; Fd&c yellow no. 5; Glyceryl behenate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Hypromellose; Povidone; Silicon dioxide; Carnauba wax; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycol
Mylan Pharamceuticals F15387 Lactose monohydrate; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
Prasco F15385 Lactose; Sodium lauryl sulfate; Fd&c yellow no. 5; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Povidone; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycols
Covis Pharmaceuticals F15384 Lactose, unspecified form; Sodium lauryl sulfate; Fd&c yellow no. 5; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycol, unspecified; Povidone, unspecified
Shionogi F15386 Lactose; Sodium lauryl sulfate; Fd&c yellow no. 5; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycols; Povidones
------------------------------------------------------------------------------------
Nisoldipine 25.5 mg tablet
Company Formulation ID FDA Description
United Research Laboratories F15392 Lactose; Sodium lauryl sulfate; Glyceryl behenate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Hypromellose; Povidone; Silicon dioxide; Carnauba wax; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycol
Physicians Total Care F15390 Lactose; Sodium lauryl sulfate; Glyceryl behenate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Povidone; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycols
Mylan Pharamceuticals F15391 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Triacetin; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
Shionogi F15406 Lactose; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycols; Povidones
------------------------------------------------------------------------------------
Nisoldipine 34 mg tablet
Company Formulation ID FDA Description
United Research Laboratories F15398 Lactose; Sodium lauryl sulfate; Glyceryl behenate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Hypromellose; Povidone; Silicon dioxide; Carnauba wax; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycol
Prasco F15395 Lactose; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Povidone; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycols
Mylan Pharamceuticals F15397 Lactose monohydrate; Sodium lauryl sulfate; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
Covis Pharmaceuticals F15394 Lactose, unspecified form; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycol, unspecified; Povidone, unspecified
Shionogi F15396 Lactose; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycols; Povidones
------------------------------------------------------------------------------------
Nisoldipine 8.5 mg tablet
Company Formulation ID FDA Description
United Research Laboratories F15405 Lactose; Sodium lauryl sulfate; Glyceryl behenate; Magnesium stearate; Ferric oxide yellow; Titanium dioxide; Hypromellose; Povidone; Silicon dioxide; Carnauba wax; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycol
Mylan Pharamceuticals F15404 Lactose monohydrate; Sodium lauryl sulfate; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
Prasco F15402 Lactose; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Povidone; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Polydextrose; Polyethylene glycols
Covis Pharmaceuticals F15401 Lactose, unspecified form; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycol, unspecified; Povidone, unspecified
Shionogi F15403 Lactose; Sodium lauryl sulfate; Glyceryl dibehenate; Magnesium stearate; Ferric oxide red; Titanium dioxide; Silicon dioxide; Carnauba wax; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycols; Povidones
------------------------------------------------------------------------------------
Nisoldipine 40 mg tablet
Company Formulation ID FDA Description
Mylan Pharamceuticals F15399 Lactose monohydrate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
Physicians Total Care F15400 Lactose monohydrate; D&c yellow no. 10; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Silicon dioxide; Hydroxypropyl cellulose; Hypromelloses; Hypromelloses; Polydextrose; Polyethylene glycols
------------------------------------------------------------------------------------
Nisoldipine 20 mg tablet
Company Formulation ID FDA Description
Mylan Pharamceuticals F15389 Lactose monohydrate; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
------------------------------------------------------------------------------------
Nisoldipine 30 mg tablet
Company Formulation ID FDA Description
Mylan Pharamceuticals F15393 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Triacetin; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Polydextrose; Polyethylene glycol, unspecified
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2524).